Cowen's best ideas for biotech is Argenx (ARGX). Yaron Werber discusses ARGX as its lead candidate "vyvgart" has been a best-in-class profile with the first mover advantage in this space. He notes that Cowen has an outperform rating with a $441 price target on ARGX. He also talks about some of Cowen's other biotech picks which include Relay Therapeutics (RPLAY) and PMV Pharmaceutical (PMVP). He then goes over the outlook for biotech in 2023. Tune in to find out more about the stock market today.
09 Dec 2022
The Watch List
17 Feb 2023
The Watch List
22 Jan 2023
Market On Close
23 Jan 2023
Market On Close
24 Feb 2023
The Watch List
31 Jan 2023
Morning Trade Live
23 Jan 2023